Many patient groups have deep ties to pharma but fail to disclose backing

Abstract: Amid ongoing debate over the role the pharmaceutical industry plays in shaping health policy, a new analysis finds that patient groups funded by drug makers generally support corporate interests, few groups have policies governing industry backing, and transparency is often lacking.